We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Biogen forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hurt by a strong dollar and ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.

President Volodymyr Zelenskyy has put into effect the decision of the National Security and Defense Council (NSDC) of ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Washington — Senator Kirsten Gillibrand announced new legislation that would, as she says, make prescription drugs more ...

California Sen. Scott Wiener’s SB 40 & SB 41 aim to reduce prescription costs with insulin affordability & PBM reform ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

Congresswoman Nikki Budzinski (IL-13) introduced the Bringing Low-Cost Options and Competition while Keeping Incentives ...

U.S. Senator Tammy Baldwin (D-WI) joined a group of her colleagues in introducing the Capping Prescription Costs Act, ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...